Lantern Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$773K Sell
8,926
-662
-7% -$63.4K 0.4% 66
2025
Q4
$921K Buy
9,588
+478
+5% +$46.4K 0.49% 55
2025
Q3
$868K Sell
9,110
-200
-2% -$18.4K 0.46% 54
2025
Q2
$812K Buy
+9,310
New +$790K 0.48% 57
2024
Q4
$756K Sell
9,469
-1,468
-13% -$127K 0.49% 50
2024
Q3
$985K Sell
10,937
-1
-0% -$84 0.68% 41
2024
Q2
$861K Hold
10,938
0.62% 44
2024
Q1
$953K Buy
10,938
+223
+2% +$19K 0.67% 44
2023
Q4
$883K Buy
+10,715
New +$817K 0.69% 41

Other funds holding MDT

Lantern Wealth Advisors's MDT Position: Q1 2026 in Review

Lantern Wealth Advisors reduced its Medtronic (MDT) stake by 6.9% in Q1 2026, selling an estimated $63.4K and leaving 8,926 shares worth $773K. The position accounts for 0.4% of the portfolio, ranked #66.

Lantern Wealth Advisors first reported a position in MDT in Q4 2023 and has held it in 9 quarters since. The position peaked at $985K in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Lantern Wealth Advisors held 8,926 shares of Medtronic worth $773K as of Q1 2026.
  • Lantern Wealth Advisors sold 662 Medtronic shares in Q1 2026, an estimated $63.4K.
  • Medtronic made up 0.4% of Lantern Wealth Advisors's portfolio in Q1 2026, its #66 holding.
  • Lantern Wealth Advisors first reported a position in Medtronic in Q4 2023 and has held it in 9 quarters since.
  • Lantern Wealth Advisors's Medtronic position peaked at $985K in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Lantern Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.